FDA Inspection 992393 — Pharmasyn, Inc.
The FDA completed an inspection of Pharmasyn, Inc. on Oct 21, 2016 in Libertyville, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 21, 2016
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Libertyville, IL (United States)